LONDON - The charity Cancer Research UK launched a £500,000 (US$814,000) research program to use RNA interference technology to systematically uncover the function of all human genes, with the ultimate aim of identifying all genes involved in cancer that would be good drug targets. (BioWorld International) Read More
